Drug Profile
Research programme: thrombin inhibitors - Roche
Alternative Names: Thrombin inhibitors research programme - RocheLatest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Roche
- Class
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Blood coagulation disorders
Most Recent Events
- 03 Feb 1998 New profile
- 03 Feb 1998 Preclinical development for Coagulation disorders in Germany (PO)